Senolysis Enabled by Senescent Cell‐Sensitive Bioorthogonal Tetrazine Ligation
Angewandte Chemie International Edition · 2024
DOI: 10.1002/anie.202315425 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2024. Verfasst von Mengyang Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona, 85721, USA. Hauptthemen laut MEDLINE: Heterocyclic Compounds, Prodrugs. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences, University of Arizona.
Abstract (Originalsprache)
Although the clearance of senescent cells has been proven to slow down the aging process and promote anti‐cancer chemotherapy, the development of senolytics remains challenging. Herein, we report a senolytic strategy enabled by senescent cell‐sensitive bioorthogonal tetrazine ligation. Our design is based on linking dihydrotetrazine (Tz) to a galactose (Gal) moiety that serves both as a recognition moiety for senescence‐associated β‐galactosidase and a caging group for the control of tetrazine activity. Gal‐Tz enables efficient click‐release of a fluorescent hemicyanine and doxorubicin from a trans ‐cyclooctene‐caged prodrug to detect and eliminate senescent HeLa and A549 cells over non‐senescent counterparts with a 16.44 senolytic index. Furthermore, we leverage the strategy for the selective activation and delivery of proteolysis‐targeting chimeras (PROTACs) as senolytics. PROTAC prodrug TCO‐ARV‐771 can be selectively activated by Gal‐Tz and delivered into senescent HeLa and A549 cells to induce the degradation of bromodomain‐containing protein 4. Senolytic PROTACs may offer an efficient way for intervention on cell senescence thanks to their unique capacity to degrade target proteins in a sub‐stoichiometric and catalytic fashion. The results of this study establish the bioorthogonal tetrazine ligation approach as a viable strategy for selective removal of senescent cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona, 85721, USA.
- Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona, 85721, USA.
- Departments of Pharmacology and Toxicology and Chemistry and Biochemistry, University of Arizona Cancer Center, and BIO5 Institute, University of Arizona, Tucson, Arizona, 85721, USA.
ORCID-Profile: Wei Wang
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- University of Arizona
Zitieren
APA
Chang, M., Dong, Y., Xu, H., Cruickshank-Taylor, A. B., Kozora, J. S., Behpour, B., & Wang, W. (2024). Senolysis Enabled by Senescent Cell‐Sensitive Bioorthogonal Tetrazine Ligation. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202315425
Vancouver
Chang M, Dong Y, Xu H, Cruickshank-Taylor AB, Kozora JS, Behpour B, et al. Senolysis Enabled by Senescent Cell‐Sensitive Bioorthogonal Tetrazine Ligation. Angewandte Chemie International Edition. 2024. doi:10.1002/anie.202315425
BibTeX
@article{Chang2024,
author = {Chang, Mengyang and Dong, Yue and Xu, Hang and Cruickshank-Taylor, Alexis B and Kozora, Jacob S and Behpour, Baran and Wang, Wei},
title = {Senolysis Enabled by Senescent Cell‐Sensitive Bioorthogonal Tetrazine Ligation},
journal = {Angewandte Chemie International Edition},
year = {2024},
doi = {10.1002/anie.202315425}
}
EUVIMED